EMBECTA CORP. Increase (Decrease) in Prepaid Expense and Other Assets
EMBECTA CORP. (EMBC) reported Increase (Decrease) in Prepaid Expense and Other Assets of $6.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $10.80M, a 0.92% decline year-over-year.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$2.70M.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$2.00M.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$5.90M, a 141.55% decline year-over-year.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$8.50M.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$39.50M, a 378.17% decline from fiscal 2023.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $14.20M, a 67.73% decline from fiscal 2022.
- EMBECTA CORP. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $44.00M, a 282.61% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $8.10M derived: sum of 2 quarters · filed 2026-08-07 | $6.10M 10-Q · filed 2026-08-07 | $200.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$4.70M 10-Q · filed 2026-05-05 | -$10.60M derived: sum of 3 quarters · filed 2026-05-05 | $300.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$2.00M 10-Q · filed 2026-02-05 | -$7.90M derived: sum of 2 quarters · filed 2026-02-05 | $3.00M derived: sum of 3 quarters · filed 2026-08-07 | -$900.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $5.00M derived: sum of 2 quarters · filed 2026-08-07 | $1.10M derived: sum of 3 quarters · filed 2026-08-07 | -$8.50M 10-K · filed 2025-11-25 |
| 2025-06-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $7.00M derived: sum of 2 quarters · filed 2026-08-07 | -$2.60M 10-Q · filed 2026-08-07 | $11.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$13.50M 10-Q · filed 2026-05-05 | $700.00K derived: sum of 3 quarters · filed 2026-05-05 | -$16.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$9.60M 10-Q · filed 2026-02-05 | $4.60M derived: sum of 2 quarters · filed 2026-02-05 | -$12.60M derived: sum of 3 quarters · filed 2026-02-05 | -$5.40M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$3.00M derived: sum of 2 quarters · filed 2025-11-25 | $4.20M derived: sum of 3 quarters · filed 2025-11-25 | -$39.50M 10-K · filed 2025-11-25 |
| 2024-06-30 | -$17.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | -$10.00M derived: sum of 2 quarters · filed 2025-08-08 | -$53.70M 10-Q · filed 2025-08-08 | -$68.70M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | -$36.50M 10-Q · filed 2025-05-09 | -$51.50M derived: sum of 3 quarters · filed 2025-11-25 | -$38.30M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | -$43.70M 10-Q · filed 2025-02-06 | -$58.70M derived: sum of 2 quarters · filed 2025-11-25 | -$45.50M derived: sum of 3 quarters · filed 2025-11-25 | -$36.10M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$1.80M derived: sum of 2 quarters · filed 2025-11-25 | $7.60M derived: sum of 3 quarters · filed 2025-11-25 | $14.20M 10-K · filed 2025-11-25 |
| 2023-06-30 | $13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $22.60M derived: sum of 2 quarters · filed 2024-08-09 | $29.20M 10-Q · filed 2024-08-09 | $47.40M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $16.00M 10-Q · filed 2024-05-09 | $34.20M derived: sum of 3 quarters · filed 2024-12-11 | $57.60M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $6.60M 10-Q · filed 2024-02-09 | $24.80M derived: sum of 2 quarters · filed 2024-12-11 | $48.20M derived: sum of 3 quarters · filed 2024-12-11 | $51.50M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | $18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $41.60M derived: sum of 2 quarters · filed 2024-12-11 | $44.90M derived: sum of 3 quarters · filed 2024-12-11 | $44.00M 10-K · filed 2024-12-11 |
| 2022-06-30 | $23.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $26.70M derived: sum of 2 quarters · filed 2023-08-08 | $25.80M 10-Q · filed 2023-08-08 | $33.30M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $2.40M 10-Q · filed 2023-05-12 | $9.90M derived: sum of 3 quarters · filed 2023-11-29 | $8.10M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | -$900.00K 10-Q · filed 2023-02-14 | $6.60M derived: sum of 2 quarters · filed 2023-11-29 | $4.80M derived: sum of 3 quarters · filed 2023-11-29 | $7.20M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $5.70M derived: sum of 2 quarters · filed 2023-11-29 | $8.10M derived: sum of 3 quarters · filed 2023-11-29 | $11.50M 10-K · filed 2023-11-29 |
| 2021-06-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $600.00K derived: sum of 2 quarters · filed 2022-08-15 | $4.00M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $5.80M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $3.40M 10-Q · filed 2022-03-16 | |||
| 2020-09-30 | -$15.40M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |